HEAD-Study Optimizing the Treatment of Children With BECTS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The investigators hypothesize that Levetiracetam is as effective as Sulthiame in the treatment of children with BECTS. Patients entering the HEAD-Studie are either treated with Leveitracetam or Sulthiame over a 6 months period. Patients are equally randomised to one of the two treatment regimens. Administration of medication as blinded capsules.
Epistemonikos ID: 8caed14f3bc92bd5a1ca74b5d34b7e2880d897fd
First added on: May 04, 2024